Chromatographic fingerprinting of ipratropium and fenoterol in their novel co-formulated inhaler treating major respiratory disorders; application to delivered dose uniformity testing along with greenness and whiteness assessment

Abstract Ipratropium bromide (IPR) and fenoterol hydrobromide (FEN) have recently been combined in a promising inhaler to treat two prevalent inflammatory illnesses of the airways: bronchial asthma and chronic obstructive pulmonary disease (COPD). The necessity for a single, sensitive, and trustwort...

Full description

Bibliographic Details
Published in:BMC Chemistry
Main Authors: Salma N. Ali, Samah S. Saad, Ahmed S. Fayed, Hoda M. Marzouk
Format: Article
Language:English
Published: BMC 2024-08-01
Subjects:
Online Access:https://doi.org/10.1186/s13065-024-01265-5